Journal Article

FZJ-2021-05143

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Polygenic risk scores across the extended psychosis spectrum

Smigielski, L. (Corresponding author) ; Papiol, S. ; Theodoridou, A. ; Heekeren, K. ; Gerstenberg, M. ; Wotruba, D. ; Buechler, R. ; Hoffmann, P. ; Herms, S. ; Adorjan, K. ; Anderson-Schmidt, H. ; Budde, M. ; Comes, A. L. ; Gade, K. ; Heilbronner, M. ; Heilbronner, U. ; Kalman, J. L. ; Klöhn-Saghatolislam, F. ; Reich-Erkelenz, D. ; Schaupp, S. K. ; Schulte, E. C. ; Senner, F. ; Anghelescu, I.-G. ; Arolt, V. ; Baune, B. T. ; Dannlowski, U. ; Dietrich, D. E. ; Fallgatter, A. J. ; Figge, C. ; Jäger, M. ; Juckel, G. ; Konrad, C. ; Nieratschker, V. ; Reimer, J. ; Reininghaus, E. ; Schmauß, M. ; Spitzer, C. ; von Hagen, M. ; Wiltfang, J. ; Zimmermann, J. ; Gryaznova, A. ; Flatau-Nagel, L. ; Reitt, M. ; Meyers, M. ; Emons, B. ; Haußleiter, I. S. ; Lang, F. U. ; Becker, T. ; Wigand, M. E. ; Witt, S. H. ; Degenhardt, F. ; Forstner, A. J.FZJ* ; Rietschel, M. ; Nöthen, M. M. ; Andlauer, T. F. M. ; Rössler, W. ; Walitza, S. ; Falkai, P. ; Schulze, T. G. ; Grünblatt, E.

2021
Nature Publishing Group London

This record in other databases:      

Please use a persistent id in citations: http://hdl.handle.net/2128/29438  doi:10.1038/s41398-021-01720-0

Abstract: As early detection of symptoms in the subclinical to clinical psychosis spectrum may improve health outcomes, knowing the probabilistic susceptibility of developing a disorder could guide mitigation measures and clinical intervention. In this context, polygenic risk scores (PRSs) quantifying the additive effects of multiple common genetic variants hold the potential to predict complex diseases and index severity gradients. PRSs for schizophrenia (SZ) and bipolar disorder (BD) were computed using Bayesian regression and continuous shrinkage priors based on the latest SZ and BD genome-wide association studies (Psychiatric Genomics Consortium, third release). Eight well-phenotyped groups (n = 1580; 56% males) were assessed: control (n = 305), lower (n = 117) and higher (n = 113) schizotypy (both groups of healthy individuals), at-risk for psychosis (n = 120), BD type-I (n = 359), BD type-II (n = 96), schizoaffective disorder (n = 86), and SZ groups (n = 384). PRS differences were investigated for binary traits and the quantitative Positive and Negative Syndrome Scale. Both BD-PRS and SZ-PRS significantly differentiated controls from at-risk and clinical groups (Nagelkerke’s pseudo-R2: 1.3–7.7%), except for BD type-II for SZ-PRS. Out of 28 pairwise comparisons for SZ-PRS and BD-PRS, 9 and 12, respectively, reached the Bonferroni-corrected significance. BD-PRS differed between control and at-risk groups, but not between at-risk and BD type-I groups. There was no difference between controls and schizotypy. SZ-PRSs, but not BD-PRSs, were positively associated with transdiagnostic symptomology. Overall, PRSs support the continuum model across the psychosis spectrum at the genomic level with possible irregularities for schizotypy. The at-risk state demands heightened clinical attention and research addressing symptom course specifiers. Continued efforts are needed to refine the diagnostic and prognostic accuracy of PRSs in mental healthcare.

---

Contributing Institute(s):

1. Strukturelle und funktionelle Organisation des Gehirns (INM-1)

Research Program(s):

1. 5251 - Multilevel Brain Organization and Variability (POF4-525) (POF4-525)

Appears in the scientific report 2021

---

Database coverage:
; ; ; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---